The study elucidated that EGCG attenuates DNMT activity and protein levels, encompassing DNMT1, DNMT3a, and DNMT3b, reinstates tumor suppressor genes, and diminishes cell proliferation, thereby offering a multifaceted approach to cancer treatment [37]. This evidence concerns the gene DNMT3A and cancer.